TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report November 7, 1997
TCL Archive Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority September 14, 1979
